Commercialization Readiness From Preclinical to First Launch: The First Time Biotech CEOs Playbook

Commercialization Readiness From Preclinical to First Launch: The First Time Biotech CEOs Playbook will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically position their organizations for financing success and meeting critical Commercial and Medical Affairs milestones.

The drug development process is complex and multifaceted, and understanding the commercialization considerations at each phase is vital. From preclinical to first product launch, this one-day course will help biotech executives make informed strategic choices for long-term success.

Beginning with Phase I, this interactive course will cover the phase-specific commercialization activities and preparation emerging companies need to make for a successful first launch, including Market analysis with competitive landscape assessment, the Commercialization Roadmap development including launch critical success factors, FTEs and dollar spend required for launch, market access pricing and reimbursement, value proposition development, and go-to-market preparation and regulatory considerations. Note these early commercial flows inform the corporate and partnering strategy at emerging biotech companies.

Russ Belden, founder and CEO of Bridge, will guide you through this course by sharing real-world examples and valuable insights. Russ is a biotech commercialization leader with over 36 years of senior operational experience in the preclinical to 1st launch space.

Takeaways

1. Identify key commercialization success factors and their value as a core, differentiating competency
2. Access a commercialization “toolbox” that can be immediately and practically applied
3. Gain a comprehensive understanding of the product launch process
4. Recognize key issues, opportunities, and challenges of effective commercialization strategy and tactics
5. Discover tools needed to build compelling and effective value-demonstration stories that help optimize reimbursement and market access